BioRestorative Therapies Inc - Company Profile
Powered by 
All the data and insights you need on BioRestorative Therapies Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date BioRestorative Therapies Inc Strategy Report
- Understand BioRestorative Therapies Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
BioRestorative Therapies Inc (BRT) is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include BRTX-100 and ThermoStem. BRTX-100, a lead therapeutic product, is designed to offer a non-surgical treatment for chronic lumbar disc diseases such as bulging and herniated discs. Its ThermoStem program develops brown fat stem cell-based therapy which is used for the treatment of type 2 diabetes, obesity, and other metabolic disorders. BRT provides identification and treatment of the first stem cell population isolated from a particular brown fat depot in humans. BRT is headquartered in Melville, New York, the US.
Headquarters
United States of America
Address
40 Marcus Drive, Melville, New York, 11747
Website
www.biorestorative.com
Telephone
1 631 7608100
No of Employees
11
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
BRTX (NASD)
Revenue (2022)
$145,800
21.7%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
22.1%
(2022 vs 2021)
Market Cap*
$8.5M
Net Profit Margin (2022)
XYZ
36.0%
(2022 vs 2021)
* As of and is in US$
BioRestorative Therapies Inc premium industry data and analytics
Products and Services
| Products | Services |
|---|---|
| BRTX- 100; Chronic Lumbar Disc Diseases | Research |
| ThermoStem; Obesity, Diabetes, Hypertension, Hyperlipidemia and Heart Related Disorders | Consultation |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Contracts/Agreements | In September, the company entered into an agreement with Evolutionary Biologics for Evolutionary Biologics for cosmetic and aesthetic applications. |
| 2023 | Contracts/Agreements | In May, the company signed an agreement with Northwell Health to participate in BioRestorative Therapies ongoing Phase 2 clinical trial targeting chronic lumber disc disease (cLDD). |
| 2022 | Contracts/Agreements | In December, the company signed an agreement with Regenexx granting BRTX exclusive license rights for intellectual property related to the development and commercialization of its BRTX-100 disc program to treat chronic lumbar disc disease. |
Competitor Comparison
| Key Parameters | BioRestorative Therapies Inc | Nature's Sunshine Products Inc | Palisade Bio Inc | Lisata Therapeutics Inc | Stemline Therapeutics Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Melville | Lehi | Carlsbad | Basking Ridge | New York |
| State/Province | New York | Utah | California | New Jersey | New York |
| No. of Employees | 11 | 814 | 9 | 25 | - |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Lance Alstodt | President; Chief Executive Officer; Chairman | Executive Board | 2020 | 52 |
| Francisco Silva | Secretary; Vice President - Research and Development; Director | Executive Board | 2020 | 48 |
| Robert Kristal | Chief Financial Officer | Senior Management | 2021 | 56 |
| Bob Paccasassi | Vice President - Quality Assurance/Regulatory Compliance | Senior Management | - | - |
| Robert Paccasassi | Vice President - Quality Assurance | Senior Management | 2021 | 54 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer